The FDA almost never tests products itself. But in May, JAMA published the results of a randomized trial, conducted by FDA researchers, to determine whether the chemicals in four commercially available sunscreens are absorbed through the skin into the bloodstream

Quick Read

After a two-year stint running the Food and Drug Administration, Scott Gottlieb has joined the board of directors at Pfizer, giving the world’s largest drug maker crucial insights into the inner workings of the Trump administration as it attempts to contain national angst over the rising cost of medicines

Quick Read

Federal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs

Quick Read

As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and disappointed that the recent approval of Novartis’ gene therapy Zolgensma was immediately overshadowed by outrage over the drug’s price: $2.125 million

Quick Read

Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday

Quick Read

In 16th- and 17th-century Europe, physicians, butchers, and executioners alike hawked the salutary effects of Axungia hominis

Quick Read

Aaron Troy writes, “Trump administration recently finalized a rule that will require drug makers to show a medication’s list price. As a future physician, I am against this change. Adding the information would make the ads less helpful and more confusing for patients, who are powerless to change the complex system…”

Quick Read

Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves

Quick Read